Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,468 | 4,805 | 5,326 | 6,619 | 6,277 |
| Receivables | 2,660 | 3,791 | 3,347 | 2,561 | 3,953 |
| Inventories | 2,282 | 1,978 | 1,377 | 857 | 881 |
| TOTAL | $9,833 | $10,948 | $10,432 | $10,165 | $11,163 |
| Non-Current Assets | |||||
| PPE Net | 2,052 | 2,031 | 2,213 | 1,634 | 1,593 |
| Intangibles | 12,709 | 12,220 | 11,804 | 6,487 | 5,661 |
| Other Non-Current Assets | -1 | 0 | 20 | 20 | 21 |
| TOTAL | $14,760 | $14,251 | $14,037 | $8,141 | $7,275 |
| Total Assets | $24,593 | $25,199 | $24,469 | $18,306 | $18,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 184 | 284 | 230 | 116 | 131 |
| TOTAL | $5,646 | $5,715 | $5,008 | $1,631 | $2,493 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,907 | 2,510 | 2,252 | 1,020 | 842 |
| Deferred Revenues | 2,800 | 2,170 | 2,103 | 616 | 449 |
| TOTAL | $3,531 | $3,220 | $3,106 | $1,556 | $1,110 |
| Total Liabilities | $9,177 | $8,935 | $8,114 | $3,187 | $3,603 |
| Shareholders' Equity | |||||
| Common Shares | 20,665 | 20,665 | 20,421 | 18,267 | 17,954 |
| Retained earnings | -6,712 | -5,674 | -5,152 | -4,242 | -4,261 |
| Other shareholders' equity | 182 | 142 | -25 | 0 | 0 |
| TOTAL | $15,416 | $16,264 | $16,355 | $15,119 | $14,835 |
| Total Liabilities And Equity | $24,593 | $25,199 | $24,469 | $18,306 | $18,438 |